This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McGlynn, K. A. Articles by Buetow, K. H. Search for Related Content PubMed PubMed Citation Articles by McGlynn, K. A. Articles by Buetow, K. H.

Hemochromatosis Gene Mutations and Distal Adenomatous Colorectal Polyps

¹ Division of Cancer Epidemiology and Genetics, ² Center for Cancer Research, and ³ Core Genotyping Facility, National Cancer Institute, NIH, Department of Health and Human Services; ⁴ University of Pittsburgh, Pittsburgh, Pennsylvania; and ⁵ M.D. Anderson Cancer Center, Houston, Texas

Request for reprints: Katherine A. McGlynn, Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, EPS-7060, 6120 Executive Boulevard, Rockville, MD 20852-7234. Phone: 301-435-4918; Fax: 301-402-0916. E-mail: mcglynnk{at}mail.nih.gov

Iron has been suggested to be a risk factor for colorectal neoplasia. Some individuals who are heterozygous for mutations in the hemochromatosis gene (HFE) have higher than average serologic measures of iron. We therefore investigated whether heterozygosity for HFE mutations was related to risk of advanced distal adenoma and whether the relationship was affected by dietary iron intake. In the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, 679 persons with advanced distal adenoma and 697 control persons were genotyped for the two major HFE mutations (C282Y and H63D), one HFE polymorphism (IVS2+4), and one polymorphism (G142S) in the transferrin receptor gene (TFRC). HFE haplotypes were also created to examine the effect of haplotype on risk. Food frequency questionnaire data were used to estimate daily iron intake. There was no relationship between any HFE genotype or haplotype and advanced adenoma. Stratification of HFE genotype by TFRC genotype did not change the results. In addition, there was no relationship between dietary iron intake and risk of adenoma or between HFE genotype and risk of adenoma, stratified by iron intake. These results do not support a relationship between HFE heterozygosity and risk of advanced distal adenoma.